Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled trial of tosufloxacin tosylate granules in children with Mycoplasma pneumoniae pneumonia
CTR20263361Phase 3Active
- Sponsor
- Towa Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tosufloxacin in Mycoplasmal pneumonia, sponsored by Towa Pharmaceutical Co., Ltd.. Started Sep 2026; status: active.
02
Drugs
tosufloxacin
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on CTR20263361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263361.